Home Page

DUBLIN, March 14, 2024 /PRNewswire/ -- The "Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By End-use, By Region, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global blood glucose monitoring devices market size is expected to reach USD 23.21 billion by 2030. The market is expected to expand at a CAGR of 8.25% from 2024 to 2030.

Patients with diabetes and their healthcare professionals benefit significantly from Blood Glucose Monitoring Devices (BGMD). BGMD is becoming more widely accepted as an important component of intensive diabetic treatment. It allows diabetic patients to measure their blood sugar levels within minutes with ease and convenience wherever they are. The continuous glucose monitoring (CGM) devices help analyze the blood glucose level continuously and in real-time. It also helps patients determine the level of dietary intake and dosage of insulin. In addition, factors such as sedentary lifestyles including consumption of junk food, alcohol, and smoking, and a surge in the need for safer and faster diagnoses are expected to boost the market growth during the forecast period.

According to the International Diabetes Federation (IDF), the total number of diabetic patients is expected to expand to 643 million (11.3 %) by 2030 and 783 million (12.2 %) by 2045. Obesity is one of the major factors propelling the prevalence of diabetes. Obese individuals are up to 80 times more likely than non-obese persons to develop diabetes. Studies suggest that 650 million people over the age of 18 are obese. Further, due to the ongoing efforts by the government and healthcare organizations such as the International Diabetes Federation (IDF) to control diabetes, the market is likely to rise at a rapid pace throughout the forecast period. Through a network of stakeholders and collaborators, these organizations provide needed expertise and support diabetes awareness campaigns. Rising health-care funding is also expected to boost market growth.

Blood Glucose Monitoring Devices Market Report Highlights

• North America held the largest revenue share in 2023 owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
• Based on product, the self-monitoring devices segment held the largest revenue share of 66.37% in 2023 and is expected to grow at a significant pace over the forecast period
• The continuous blood glucose monitoring devices product segment is expected to be the fastest-growing segment during the forecast period
• In the self-monitoring devices, the testing strips segment accounted for the largest revenue share in 2023 owing to the high usage of these strips and affordability.
• By end-use, the home care segment is expected to grow at a rapid pace during the forecast period

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Blood Glucose Monitoring Devices Market: Executive Summary

2.1. Market Snapshot

2.2. Products and End Use Snapshots

2.3. Competitive Landscape Snapshot

Chapter 3. Blood Glucose Monitoring Devices Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope

3.2. Market Lineage Outlook

3.3. Market Dynamics

3.4. Market Drivers Analysis

3.4.1. Rising geriatric population worldwide

3.4.2. Increasing number of diabetes patients

3.4.3. Increasing awareness about diabetes preventive care

3.5. Market Restraint Analysis

3.5.1. High cost of devices

3.6. Blood Glucose Monitoring Devices Market Analysis Tools

Chapter 4. Blood Glucose Monitoring Devices: Product Estimates & Trend Analysis

4.1. Global Blood Glucose Monitoring Market: Product Segment Dashboard

4.2. Global Blood Glucose Monitoring Devices Market by Product Outlook

4.3. Global Blood Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)

4.4. Self-Monitoring Devices

4.4.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

4.4.2. Blood Glucose Meter

4.4.3. Testing Strips

4.4.4. Lancets

4.5. Continuous Blood Glucose Monitoring Devices

4.5.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)

4.5.2. Sensors

4.5.3. Transmitter & Receiver

4.5.4. Insulin Pumps

Chapter 5. Blood Glucose Monitoring Devices: End-use Estimates & Trend Analysis

5.1. Global Blood Glucose Monitoring Market: End-use Segment Dashboard

5.2. Global Blood Glucose Monitoring Market: End-use Movement Analysis

5.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)

5.4. Hospitals

5.5. Homecare

5.6. Diagnostics Centers

Chapter 6. Regional Business Analysis

6.1. Regional Market Dashboard

6.2. Global Regional Market Snapshot

6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:

6.4. North America

6.4.1. U.S.

6.4.2. Canada

6.5. Europe

6.5.1. UK

6.5.2. Germany

6.5.3. Spain

6.5.4. France

6.5.5. Italy

6.5.6. Denmark

6.5.7. Sweden

6.5.8. Norway

6.6. Asia Pacific

6.6.1. Japan

6.6.2. China

6.6.3. India

6.6.4. South Korea

6.6.5. Thailand

6.6.6. Australia

6.7. Latin America

6.7.1. Brazil

6.7.2. Mexico

6.7.3. Argentina

6.8. MEA

6.8.2. Saudi Arabia

6.8.3. UAE

6.8.4. Kuwait

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants

7.2. Company /Competition Categorization

7.3. Vendor Landscape

• Abbott
• Medtronic
• F. Hoffmann-La Roche
• Ascensia Diabetes Care Holdings
• LifeScan IP Holdings
• Dexcom
• SANOFI
• Elly Lilly
• B Braun

For more information about this report visit https://www.researchandmarkets.com/r/y18k6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

 

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/blood-glucose-monitoring-devices-market-size-share--trends-analysis-report-2024-2030-the-self-monitoring-devices-segment-held-the-largest-revenue-share-of-66-in-2023-302089221.html

SOURCE Research and Markets